Zobrazeno 1 - 10
of 17
pro vyhledávání: '"L. V. Shukil"'
Publikováno v:
Безопасность и риск фармакотерапии, Vol 10, Iss 3, Pp 251-258 (2022)
The main pharmacoepidemiological method for assessing the efficacy and safety of ongoing pharmacotherapy involves the collection of spontaneous reports on adverse drug reactions (ADRs) associated with the use of medicines.The aim of the study was to
Externí odkaz:
https://doaj.org/article/80c282c117a04acba2d0222357eb5c66
Autor:
I. V. Druk, O. Yu. Korennova, Yu. E. Yukhina, M. V. Savchenko, N. A. Maciyauskas, L. V. Shukil
Publikováno v:
Российский кардиологический журнал, Vol 27, Iss 10 (2022)
Aim. To study the prevalence of hyporesponse to statin therapy and its impact on the development of heart failure (HF) among patients after acute coronary syndrome (ACS) in a short-term follow-up.Material and methods. This retrospective analysis of o
Externí odkaz:
https://doaj.org/article/c734bd26f7204e7aa667fa2aecfa2d5c
Publikováno v:
Российский кардиологический журнал, Vol 0, Iss 8, Pp 45-51 (2018)
Aim. Clinical economical grounding of necessity for continuation of a “State Managed Program of Omsk Region “Development of Healthcare in Omsk Region” (the Program) in allowance granted supply with life saving medications of patients after endo
Externí odkaz:
https://doaj.org/article/cf99fc491c0c486c9d062885d142868d
Autor:
O. Yu. Korennova, L. V. Shukil', S. N. Mal'tsev, I. A. Klinyshkov, N. M. Leganova, E. A. Turusheva, T. V. Kropotina
Publikováno v:
Фармакоэкономика, Vol 9, Iss 1, Pp 39-48 (2016)
Objective. Carrying out of the comparative clinical and economic analysis of treatment of patients with rheumatic diseases (RD) by genetically engineered biological agents (GEBA) in conditions of round-the-clock and day-time in-patient departments.Ma
Externí odkaz:
https://doaj.org/article/e0239e548efe40ca98d8e45f762fd932
Publikováno v:
Фармация и фармакология (Пятигорск), Vol 3, Iss 3(10), Pp 33-39 (2015)
The monitoring of drug supply availability to the population in the frameworks of state guarantees and timely revelation of problems appeared is one of the most important issues of Russian healthcare. Revelation of prevailing problems connected with
Externí odkaz:
https://doaj.org/article/c99f4f4e27b44230b5f1559cec95b25e
Autor:
E. A. Ryapolova, I. V. Druk, E. P. Prihodko, E. A. Turusheva, O. Yu. Korennova, M. V. Savchenko, Yu. E. Yukhina, L. V. Shukil, S. P. Podolnaya
Publikováno v:
Complex Issues of Cardiovascular Diseases. 10:16-25
Aim. To determine the clinical factors affecting the timely reference of patients with coronary artery disease after myocardial revascularization to Phase 3 cardiac rehabilitation.Methods. 773 patients with coronary artery disease (CAD) who underwent
Autor:
L V Shukil’, L V Moshkova
Publikováno v:
RUDN Journal of Medicine, Vol 0, Iss S6, Pp 130-133 (2013)
The structure of Drugs Quality Control System in Omsk region was characterized. The processes of services life cycle in regional Drugs Center were considered in a framework of active Drugs Quality Management System.
Externí odkaz:
https://doaj.org/article/8e9a0b448ae14ae198aa33e82c0a94c3
Autor:
S. N. Mal'tsev, O. Yu. Korennova, I. A. Klinyshkov, N. M. Leganova, L. V. Shukil, T. V. Kropotina, E. A. Turusheva
Publikováno v:
Фармакоэкономика, Vol 9, Iss 1, Pp 39-48 (2016)
Objective. Carrying out of the comparative clinical and economic analysis of treatment of patients with rheumatic diseases (RD) by genetically engineered biological agents (GEBA) in conditions of round-the-clock and day-time in-patient departments. M
Publikováno v:
Pharmaceutical Chemistry Journal. 40:5-7
The experimental pharmacokinetics of the new antioxidant preparations — fenozan acid and fenoxan (potassium salt of fenozan acid) — were studied in rabbits by monitoring the concentration profiles of the drugs in the blood plasma. Upon peroral ad
Autor:
A. S. Berlyand, E. V. Ufimtseva, L. V. Shukil, N. V. Veselovskaya, A. A. Prokopov, M. V. Belova
Publikováno v:
Pharmaceutical Chemistry Journal. 34:273-275